ADBRY Injection Drug Recall for Particulate Contamination
LEO Pharma is recalling its ADBRY injection drug due to particulate matter (wool fiber) found in one unit, which may affect sterility. The recall covers 11,407 units distributed nationwide.
- Product
- ADBRY — ADBRY (TRALOKINUMAB-LDRM)
- Category
- Drug
- Distribution
- Distributed nationwide